AMAG PHARMACEUTICALS, INC. short interest in 2018
In 2018, AMAG PHARMACEUTICALS, INC.'s disclosed short interest ran from 23.55% of shares outstanding on 12 Jan 2018 to 26.15% on 31 Dec 2018, a change of +2.60 percentage points. The year's high was 32.92% on 31 Jul 2018 and its low 23.55% on 12 Jan 2018, averaging 28.24% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.70 days on 31 Aug 2018. Full history: AMAG PHARMACEUTICALS, INC..
Cite this page
2018 in figures
- Start of year
- 23.55% (12 Jan 2018)
- End of year
- 26.15% (31 Dec 2018)
- Change
- +2.60 pp
- High
- 32.92% (31 Jul 2018)
- Low
- 23.55% (12 Jan 2018)
- Average
- 28.24%
- Highest days to cover
- 25.70 (31 Aug 2018)
- SEC filings marked
- 10
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 23.55% | 10.00 | results (8-K) |
| 31 Jan 2018 | 23.58% | 10.23 | |
| 15 Feb 2018 | 26.10% | 3.98 | results (8-K) |
| 28 Feb 2018 | 27.69% | 5.86 | results (8-K) |
| 15 Mar 2018 | 28.48% | 10.38 | 10-K filed |
| 29 Mar 2018 | 26.48% | 9.80 | |
| 13 Apr 2018 | 26.96% | 11.48 | |
| 30 Apr 2018 | 27.27% | 18.06 | |
| 15 May 2018 | 28.34% | 8.95 | results (8-K), 10-Q filed |
| 31 May 2018 | 29.55% | 19.81 | |
| 15 Jun 2018 | 31.78% | 11.89 | |
| 29 Jun 2018 | 32.26% | 11.30 | |
| 13 Jul 2018 | 31.57% | 23.59 | |
| 31 Jul 2018 | 32.92% | 20.69 | |
| 15 Aug 2018 | 30.10% | 17.37 | results (8-K), 10-Q filed |
| 31 Aug 2018 | 29.75% | 25.70 | |
| 14 Sep 2018 | 29.75% | 21.55 | |
| 28 Sep 2018 | 26.64% | 10.94 | |
| 15 Oct 2018 | 26.46% | 13.04 | |
| 31 Oct 2018 | 28.14% | 15.04 | |
| 15 Nov 2018 | 29.25% | 7.74 | results (8-K), 10-Q filed |
| 30 Nov 2018 | 28.31% | 19.57 | |
| 14 Dec 2018 | 26.79% | 14.46 | |
| 31 Dec 2018 | 26.15% | 14.42 |
See also: AMAG PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.